STOCK TITAN

Daniel O'Day plans 115640-share Gilead (NASDAQ: GILD) stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Daniel O'Day filed to sell 115640 shares of Gilead common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 17346000.00 and 1240679623 Gilead shares outstanding.

The 115640 shares were acquired on 02/05/2026 via a stock option exercise from the issuer, paid in cash on the same date. Over the prior three months, O'Day sold additional Gilead common shares in four trades totaling 145640 shares for gross proceeds of 187627,? wait.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Daniel O'Day’s Form 144 filing for GILD disclose?

The filing discloses Daniel O'Day’s intent to sell 115640 shares of Gilead common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an indicated aggregate market value of 17346000.00 and 1240679623 Gilead shares reported as outstanding.

How many Gilead (GILD) shares does Daniel O'Day plan to sell?

Daniel O'Day plans to sell 115640 shares of Gilead common stock. These shares were acquired on 02/05/2026 via a stock option exercise from the issuer and are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.

How were the 115640 Gilead shares in the Form 144 acquired?

The 115640 Gilead common shares were acquired on 02/05/2026 through a stock option exercise from the issuer. Payment for these shares was made in cash on the same date, according to the acquisition and payment information disclosed in the Form 144 filing.

What recent Gilead (GILD) share sales has Daniel O'Day reported?

Over the past three months, Daniel O'Day reported four sales of Gilead common stock: three sales of 10000 shares each and one sale of 115640 shares, on 11/28/2025, 12/29/2025, 01/23/2026, and 01/28/2026, with disclosed gross proceeds for each transaction.

What is the market value of the Gilead shares in this Form 144?

The Form 144 lists an aggregate market value of 17346000.00 for the 115640 Gilead common shares to be sold. This value appears in the securities information table alongside the planned sale amount and the number of Gilead shares reported as outstanding.

How many Gilead (GILD) shares are reported outstanding in the filing?

The Form 144 states that 1240679623 shares of Gilead common stock are outstanding. This outstanding share count appears in the securities information table and serves as a baseline context for the size of the 115640-share planned sale by Daniel O'Day.
Gilead Sciences Inc

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Latest SEC Filings

GILD Stock Data

185.32B
1.24B
0.1%
90.75%
1.42%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
FOSTER CITY